194 related articles for article (PubMed ID: 34286169)
1. A Pilot Trial: Fish Oil and Metformin Effects on ApoB-Remnants and Triglycerides in Women With Polycystic Ovary Syndrome.
Vine D; Proctor E; Weaver O; Ghosh M; Maximova K; Proctor S
J Endocr Soc; 2021 Sep; 5(9):bvab114. PubMed ID: 34286169
[TBL] [Abstract][Full Text] [Related]
2. Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents With Polycystic Ovary Syndrome.
Vine DF; Wang Y; Jetha MM; Ball GD; Proctor SD
J Clin Endocrinol Metab; 2017 Mar; 102(3):970-982. PubMed ID: 27997268
[TBL] [Abstract][Full Text] [Related]
3. ApoB48-Lipoproteins Are Associated with Cardiometabolic Risk in Adolescents with and without Polycystic Ovary Syndrome.
Vine DF; Beilin LJ; Burrows S; Huang RC; Hickey M; Hart R; Proctor SD; Mori TA
J Endocr Soc; 2020 Aug; 4(8):bvaa061. PubMed ID: 32803089
[TBL] [Abstract][Full Text] [Related]
4. ApoB-lipoprotein remnant dyslipidemia and high-fat meal intolerance is associated with markers of cardiometabolic risk in youth with obesity.
Krysa JA; Ball GDC; Vine DF; Jetha M; Proctor SD
Pediatr Obes; 2021 May; 16(5):e12745. PubMed ID: 33150705
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
6. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.
Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G
Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959
[TBL] [Abstract][Full Text] [Related]
7. The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response.
Ooi TC; Krysa JA; Chaker S; Abujrad H; Mayne J; Henry K; Cousins M; Raymond A; Favreau C; Taljaard M; Chrétien M; Mbikay M; Proctor SD; Vine DF
J Clin Endocrinol Metab; 2017 Sep; 102(9):3452-3460. PubMed ID: 28673045
[TBL] [Abstract][Full Text] [Related]
8. Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
Glintborg D; Sidelmann JJ; Altinok ML; Mumm H; Andersen M
Metabolism; 2015 Oct; 64(10):1272-8. PubMed ID: 26194691
[TBL] [Abstract][Full Text] [Related]
9. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
Zhang J; Xing C; Cheng X; He B
Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
[TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitus.
Burggraaf B; Pouw NMC; Arroyo SF; van Vark-van der Zee LC; van de Geijn GM; Birnie E; Huisbrink J; van der Zwan EM; Mulder MT; Rensen PCN; de Herder WW; Cabezas MC
Diabetes Obes Metab; 2020 May; 22(5):807-816. PubMed ID: 31912632
[TBL] [Abstract][Full Text] [Related]
11. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
[TBL] [Abstract][Full Text] [Related]
12. Postprandial lipaemia following consumption of a meal enriched with medium chain saturated and/or long chain omega-3 polyunsaturated fatty acids. A randomised cross-over study.
Austin G; Ferguson JJ; Thota RN; Singh H; Burrows T; Garg ML
Clin Nutr; 2021 Feb; 40(2):420-427. PubMed ID: 32684486
[TBL] [Abstract][Full Text] [Related]
13. Acute fish oil and soy isoflavone supplementation increase postprandial serum (n-3) polyunsaturated fatty acids and isoflavones but do not affect triacylglycerols or biomarkers of oxidative stress in overweight and obese hypertriglyceridemic men.
Hanwell HE; Kay CD; Lampe JW; Holub BJ; Duncan AM
J Nutr; 2009 Jun; 139(6):1128-34. PubMed ID: 19339704
[TBL] [Abstract][Full Text] [Related]
14. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
17. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
[TBL] [Abstract][Full Text] [Related]
18. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
19. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
20. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
Roe A; Hillman J; Butts S; Smith M; Rader D; Playford M; Mehta NN; Dokras A
J Clin Endocrinol Metab; 2014 May; 99(5):E841-7. PubMed ID: 24512495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
